CA
HALO icon

Corrado Advisors’s Halozyme HALO Stock Holding History

Corrado Advisors’s Portfolio HALO Stock Details HALO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-44,965
Closed -$444K – 71
2014
Q2 		$444K Sell
44,965
-8,150
-15% -$69.1K 0.19% 51
2014
Q1 		$675K Sell
53,115
-30,650
-37% -$455K 0.33% 38
2013
Q4 		$1.26M Sell
83,765
-43,130
-34% -$555K 0.57% 26
2013
Q3 		$1.4M Buy
+126,895
New +$1.06M 0.74% 21

Other funds holding HALO

TS
Third Security Radford, Virginia $241M AUM 45.43% 1-Year Est. Return
IAM
Iridian Asset Management Westport, Connecticut $247M AUM 20.65% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return
QF
QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Corrado Advisors's HALO Position: Q3 2014 in Review

Corrado Advisors sold out of Halozyme (HALO) in Q3 2014, closing a stake of 44,965 shares — an estimated $444K sold.

Corrado Advisors first reported a position in HALO in Q3 2013 and held it in 4 quarters. The position peaked at $1.4M in Q3 2013. 121 funds tracked by Wall St. Rank hold HALO as of Q3 2014.

  • Corrado Advisors reported no remaining Halozyme position as of Q3 2014 after selling out during the quarter.
  • Corrado Advisors sold 44,965 Halozyme shares in Q3 2014, an estimated $444K.
  • Corrado Advisors first reported a position in Halozyme in Q3 2013 and held it in 4 quarters.
  • Corrado Advisors's Halozyme position peaked at $1.4M in Q3 2013.
  • 121 funds tracked by Wall St. Rank held Halozyme as of Q3 2014.

Based on Corrado Advisors's 13F filing for Q3 2014, filed 10 Oct 2014.